AMSTERDAM, January 5, 2022 / PRNewswire / – VEON Ltd. (NASDAQ: VEON) (Euronext Amsterdam: VEON), a leading global provider of connectivity and internet services, today announced that Karen Linehan, former General Counsel of Sanofi, has joined the board of directors of VEON as a non-executive director.
Karen has spent over 30 years at Sanofi, a leading global healthcare company, in various legal roles, including over a decade as General Counsel, leading the Legal, Ethics and Business Integrity function. . Together with her global team, she has effectively protected the company and its stakeholders from the many challenges of the rapidly changing environment of the pharmaceutical industry.
As one of the first women on the Sanofi Executive Committee and a founding member of the company’s Gender Balance Board, Karen was also a passionate advocate for diversity, gender equality and personal development. His previous professional experience includes the practice of law in the New York Townley & Updike law firm, and on the Congressional Staff of the Speaker of the United States House of Representatives.
Karen graduated from Georgetown University with a Bachelor of Arts in American Studies and a Doctorate of Laws.
Gennady Gazin, Chairman of the Board, said, “We welcome Karen as an independent director to our board, and we look forward to working with her. Karen brings a wealth of experience and a valuable perspective to our company. We are delighted that she is serving on our audit and risk and nominating and corporate governance committees. “
Karen’s appointment fills the vacancy created by the resignation of Steve Pusey Last year.
VEON is a global connectivity and digital services provider listed on NASDAQ and Euronext Amsterdam. Our businesses are transforming lifestyles with technology-driven services that provide opportunities in some of the world’s fastest growing emerging markets. For more information visit: https://www.veon.com
This press release contains “forward-looking statements” as defined in Section 27A of the US Securities Act of 1933, as amended, and Section 21E of the US Securities Exchange Act of 1934, as amended. Forward-looking statements are not historical facts and include statements relating, among other things, to the potential benefits of the appointment described above. Forward-looking statements are inherently subject to risks and uncertainties, many of which cannot be predicted with precision and some of which may not even be anticipated by VEON. The forward-looking statements contained in this press release speak only as of the date of this press release. VEON does not undertake to publicly update, except as required by US federal securities laws, any forward-looking statements to reflect events or circumstances after these dates or to reflect the occurrence of unforeseen events. In addition, elements of this press release contain or may contain “inside information” as defined in the Market Abuse Regulation (EU) No 596/2014.
Group communications director
Group Investor Relations Director
Phone: +31 20 79 77 200
SOURCE VEON Ltd.